Socioeconomic status impacts survival and access to resection in pancreatic adenocarcinoma: A high-resolution population-based cancer registry study

被引:14
作者
Thobie, Alexandre [1 ,2 ,4 ]
Mulliri, Andrea [1 ,3 ]
Dolet, Nathan [2 ,4 ]
Eid, Yassine [1 ,2 ,4 ]
Bouvier, Veronique [2 ,3 ,4 ]
Launoy, Guy [2 ,3 ,4 ]
Alves, Arnaud [1 ,2 ,3 ,4 ]
Dejardin, Olivier [2 ,4 ]
机构
[1] Univ Hosp Caen, Dept Digest Surg, Ave Cote Nacre, F-14032 Caen, France
[2] Univ Normandy, UMR INSERM ANTICIPE 1086, Caen, France
[3] Registre Tumeurs Digest Calvados, Paris, France
[4] Univ Hosp Caen, Dept Res, Caen, France
来源
SURGICAL ONCOLOGY-OXFORD | 2018年 / 27卷 / 04期
关键词
Socioeconomic status; Pancreatic adenocarcinoma; Surgery; Survival; Deprivation; RISK-FACTORS; ENGLAND; STAGE; DETERMINANTS; DISPARITIES; MORTALITY; OUTCOMES; INDEX; WALES; CARE;
D O I
10.1016/j.suronc.2018.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Survival of patients with pancreatic adenocarcinoma (PA) is very poor. Resection status is highly associated with prognosis but only 15%-20% are resectable. The aim of this study was to analyse the impact of socioeconomic deprivation on PA survival and to define which management steps are affected. Methods: Between 01/01/2000 and 31/12/2014, 1451 incident cases of PA recorded in the digestive cancer registry of the French department of Calvados were included. The population was divided between less deprived areas (quintile 1) and more deprived areas (quintile 2,3,4,5 aggregated). Results: Patients from less deprived areas were younger at diagnosis than those from more deprived areas (69.9 vs 72.3 years, p = 0.01). There was no difference in stage or comorbidities. Three- and 5-year survival rates were significantly higher for less deprived areas than more deprived areas: 10.5% vs 5.15% and 4.7% vs 1.7% respectively (p = 0.01). In univariate analysis, those living in less deprived areas had a better survival than those in more deprived areas (HR = 0.81 [0.69-0.95], p = 0.009) but not in multivariable analysis (HRa = 0.93 [0.79-1.11], p = 0.383) or analysis stratified on resection. In multivariable regression, less deprived areas had more access to surgery than more deprived areas (ORa = 1.73 [1.08-2.47], p = 0.013). No difference was observed on access to adjuvant chemotherapy (ORa = 0.95 [0.38-2.34], p = 0.681). Conclusion: The key to reducing survival inequalities in PA is access to resection, so future studies should investigate the factors impacting this issue.
引用
收藏
页码:759 / 766
页数:8
相关论文
共 44 条
[1]   Disparities in Pancreas Cancer Care [J].
Abraham, Anasooya ;
Al-Refaie, Waddah B. ;
Parsons, Helen M. ;
Dudeja, Vikas ;
Vickers, Selwyn M. ;
Habermann, Elizabeth B. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (06) :2078-2087
[2]   Pancreatic cancer: yesterday, today and tomorrow [J].
Ansari, Daniel ;
Tingstedt, Bobby ;
Andersson, Bodil ;
Holmquist, Fredrik ;
Sturesson, Christian ;
Williamsson, Caroline ;
Sasor, Agata ;
Borg, David ;
Bauden, Monika ;
Andersson, Roland .
FUTURE ONCOLOGY, 2016, 12 (16) :1929-1946
[3]   Predictive Global Trends in the Incidence and Mortality of Pancreatic Cancer Based on Geographic Location, Socio-Economic Status, and Demographic Shift [J].
Are, Chandrakanth ;
Chowdhury, Sanjib ;
Ahmad, Humera ;
Ravipati, Advaitaa ;
Song, Tianqiang ;
Shrikandhe, Shailesh ;
Smith, Lynette .
JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (06) :736-742
[4]   Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994-2003 [J].
Baastrup, Rikke ;
Sorensen, Mette ;
Hansen, Johnni ;
Hansen, Rikke Dalgaard ;
Wurtzen, Hanne ;
Winther, Jeanette Falck .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (14) :1962-1977
[5]   Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands [J].
Bakens, Maikel J. A. M. ;
Lemmens, Valery E. P. P. ;
de Hingh, Ignace H. J. T. .
HPB, 2017, 19 (05) :443-448
[6]   Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study [J].
Batty, G. David ;
Kivimaki, Mika ;
Morrison, David ;
Huxley, Rachel ;
Smith, George Davey ;
Clarke, Robert ;
Marmot, Michael G. ;
Shipley, Martin J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :673-675
[7]   Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged? [J].
Bertens, Kimberly A. ;
Massman, John D. ;
Helton, Scott ;
Garbus, Samuel ;
Mandelson, Margaret M. ;
Lin, Bruce ;
Picozzi, Vincent J. ;
Biehl, Thomas ;
Alseidi, Adnan A. ;
Rocha, Flavio G. .
JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (08) :1655-1663
[8]   National failure to operate on early stage pancreatic cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
ANNALS OF SURGERY, 2007, 246 (02) :173-180
[9]   Focus on an unusual rise in pancreatic cancer incidence in France [J].
Bouvier, Anne-Marie ;
Uhry, Zoe ;
Jooste, Valerie ;
Drouillard, Antoine ;
Remontet, Laurent ;
Launoy, Guy ;
Leone, Nathalie .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (06) :1764-1772
[10]   Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study [J].
Burmeister, E. A. ;
Waterhouse, M. ;
Jordan, S. J. ;
O'Connell, D. L. ;
Merrett, N. D. ;
Goldstein, D. ;
Wyld, D. ;
Beesley, V. ;
Gooden, H. ;
Janda, M. ;
Neale, R. E. .
PANCREATOLOGY, 2016, 16 (05) :873-881